VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 226 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,166 | -16.0% | 131 | -4.4% | 0.00% | – |
| Q1 2024 | $1,388 | -21.6% | 137 | -22.2% | 0.00% | – |
| Q4 2023 | $1,771 | -40.2% | 176 | -44.3% | 0.00% | -100.0% |
| Q3 2023 | $2,961 | -84.1% | 316 | -58.3% | 0.00% | -80.0% |
| Q2 2023 | $18,594 | +18.2% | 758 | +12.1% | 0.01% | +25.0% |
| Q1 2023 | $15,731 | -24.1% | 676 | -17.5% | 0.00% | -33.3% |
| Q4 2022 | $20,729 | +130.3% | 819 | +76.9% | 0.01% | +100.0% |
| Q3 2022 | $9,000 | +12.5% | 463 | +44.7% | 0.00% | +50.0% |
| Q2 2022 | $8,000 | -33.3% | 320 | +11.9% | 0.00% | -33.3% |
| Q4 2021 | $12,000 | – | 286 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $39,700,000 | 30.52% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $565,858,000 | 4.50% |
| Zebra Capital Management LLC | 25,419 | $647,000 | 1.90% |
| Alaska Permanent Fund Corp | 2,300,000 | $58,581,000 | 0.84% |
| CLARK ESTATES INC/NY | 180,000 | $4,585,000 | 0.79% |
| Temasek Holdings (Private) Ltd | 5,602,553 | $142,697,025 | 0.78% |
| SECTOR GAMMA AS | 110,223 | $2,807,000 | 0.63% |
| Avidity Partners Management LP | 758,211 | $19,312,000 | 0.44% |
| New Vernon Capital Holdings II LLC | 14,501 | $369,000 | 0.30% |
| DUALITY ADVISERS, LP | 116,415 | $2,965,000 | 0.29% |